Template:Vaginal bleeding definitions: Difference between revisions

Line 5: Line 5:
*Intermenstrual bleeding: variable amounts between regular menstrual periods
*Intermenstrual bleeding: variable amounts between regular menstrual periods
*Midcycle spotting: spotting just before ovulation (due to decline in estrogen)
*Midcycle spotting: spotting just before ovulation (due to decline in estrogen)
*Postmenopausal bleeding: recurrence of bleeding after menopause
*Postmenopausal bleeding: recurrence of bleeding >6 mo after menopause
*Polymenorrhea: frequent and light bleeding
*Polymenorrhea: frequent and light bleeding
*Postcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology
*Postcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology
*Postmenopausal bleeding: any bleeding that occurs >6 mo after cessation of menstruation


*The International Federation of Gynecology and Obstetrics (FIGO) introduced a new classification system known by the acronym PALM-COEIN
*The International Federation of Gynecology and Obstetrics (FIGO) introduced a new classification system known by the acronym PALM-COEIN

Revision as of 18:25, 12 January 2021

Vaginal Bleeding Definitions

  • Menorrhagia: >7 day (prolonged) or >80 mL/day (excessive) uterine bleeding at regular intervals
  • Metrorrhagia: irregular vaginal bleeding outside the normal cycle
  • Menometrorrhagia: excessive irregular vaginal bleeding
  • Intermenstrual bleeding: variable amounts between regular menstrual periods
  • Midcycle spotting: spotting just before ovulation (due to decline in estrogen)
  • Postmenopausal bleeding: recurrence of bleeding >6 mo after menopause
  • Polymenorrhea: frequent and light bleeding
  • Postcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology
  • The International Federation of Gynecology and Obstetrics (FIGO) introduced a new classification system known by the acronym PALM-COEIN
  • PALM: structural causes
    • Polyp (AUB-P)
    • Adenomyosis (AUB-A)
    • Leiomyoma (AUB-L)
    • Malignancy and hyperplasia (AUB-M)
  • COEIN: nonstructural causes
    • Coagulopathy (AUB-C)
    • Ovulatory dysfunction (AUB-O)
    • Endometrial (AUB-E)
    • Iatrogenic (AUB-I)
    • Not yet classified (AUB-N)